Climate change and health innovation: how life sciences are responding to a warming world

Climate change is increasingly recognised not only as an environmental crisis, but as a public health challenge. Rising temperatures, extreme weather events and shifting patterns of infectious disease are placing new pressures on healthcare systems. At the same time, the health sector itself contributes significantly to carbon emissions through energy use, supply chains and waste. In response, life sciences and healthcare innovators are working to address both sides of the equation: mitigating environmental impact while adapting to emerging health risks.

The health impacts of climate change

The effects of climate change on health are already visible. Heatwaves increase the risk of dehydration, cardiovascular events and respiratory illness, particularly among older adults and vulnerable populations. Flooding and extreme weather disrupt healthcare delivery and infrastructure.

Changing climates also influence the spread of infectious diseases. Warmer temperatures can expand the habitats of disease-carrying insects, while global movement and environmental change alter transmission patterns. Air pollution, closely linked to fossil fuel use, remains a major contributor to respiratory and cardiovascular conditions.

For healthcare systems such as the NHS, these trends mean rising demand and new forms of pressure.

Decarbonising healthcare delivery

Healthcare is energy intensive. Hospitals operate around the clock, rely on complex equipment and generate significant waste. Reducing the carbon footprint of health services has become a strategic priority.

Innovation is playing a central role. Renewable energy installations, energy-efficient building design and electrification of vehicle fleets are helping to lower emissions. Advances in sustainable procurement and supply chain transparency are also reducing the environmental impact of medical products.

In the life sciences sector, laboratories are exploring greener practices, from reducing single-use plastics to improving energy efficiency in research facilities. Sustainable manufacturing processes for pharmaceuticals and medical devices are becoming a focus of industry investment.

Climate-resilient healthcare systems

Adaptation is as important as mitigation. Health systems must be prepared to cope with extreme weather events and shifting disease burdens. Digital health tools and remote monitoring technologies can help maintain continuity of care during disruptions.

Predictive analytics may support early warning systems for heat-related illness or infectious disease outbreaks. By analysing environmental and health data together, researchers can anticipate risk and inform public health responses.

Urban planning and healthcare infrastructure design are also evolving. Cooling strategies, flood-resistant construction and resilient supply chains are essential components of climate-ready health systems.

Innovation in therapeutics and prevention

Life sciences research is contributing directly to climate-related health challenges. Vaccine development and infectious disease research are adapting to changing patterns of transmission. Public health campaigns promoting healthier diets and active travel not only reduce carbon emissions but also lower the risk of chronic diseases.

There is growing recognition that environmental sustainability and public health objectives can align. For example, reducing air pollution improves respiratory health while contributing to climate mitigation goals.

The UK’s leadership opportunity

The UK has committed to ambitious climate targets, and the healthcare sector has a defined pathway towards net zero. This creates both a responsibility and an opportunity for innovation.

With strengths in research, biotechnology and digital health, the UK is well placed to pioneer sustainable healthcare solutions. Partnerships between academia, industry and the NHS are crucial to translating climate-focused research into practical change.

Investment in green technologies, alongside regulatory frameworks that support sustainable innovation, can position the UK as a global leader in environmentally responsible healthcare.

Ethical and equity considerations

Climate change does not affect all communities equally. Vulnerable populations often face the greatest health risks, from heat exposure to poor air quality. Ensuring that adaptation strategies prioritise those most at risk is essential.

Equity must also guide the development of sustainable technologies. Access to resilient healthcare infrastructure and innovative treatments should not be limited by geography or income.

Looking ahead

As the climate crisis intensifies, the intersection between environmental sustainability and health innovation will grow ever more significant. Healthcare systems must evolve to reduce their environmental footprint while preparing for new health challenges.

Life sciences innovation offers tools to meet this dual challenge, from greener manufacturing to predictive public health analytics. By integrating sustainability into research, development and service delivery, the sector can contribute meaningfully to both planetary and human health.

Conclusion

Climate change is reshaping the context in which healthcare operates. The response requires coordinated action across policy, research and clinical practice. Through sustainable technologies, resilient infrastructure and targeted innovation, the life sciences community has a critical role to play.

For the UK, the challenge is substantial but so is the opportunity. By aligning health innovation with climate responsibility, the country can help ensure that future healthcare systems are not only more advanced, but more sustainable and equitable as well.

Author

Leave A Comment

Apply for a complimentary Conference Day VIP Pass

Apply for a complimentary Conference Day VIP Pass

Complimentary Conference Day VIP Passes are reserved for senior leaders and decision-makers with influence over purchasing, commissioning, investment or technology advancements and adoption across UK life sciences.

A Conference Day VIP Pass includes:

  • Complimentary access-all-areas to the Launch Day Conference
  • Access to the dedicated VIP green room alongside Conference speakers
  • Access to all general keynote, panel and programme sessions
  • Curated networking opportunities
  • Opportunities to meet conference speakers and other approved VIP attendees

The VIP Pass applies to the Launch Day Conference only. It does not include admission to the Life Sciences Week Gala Dinner or other separately ticketed events.

Applications are reviewed individually and submitting this form does not guarantee a complimentary pass. To maintain a balanced, high-quality audience, we may limit the number of VIP Passes issued to any one organisation.

    First Name *

    Last Name *

    Work Email Address *

    Telephone Number *

    Job Title *

    Organisation *

    LinkedIn

    Organisation Information

    Which best describes your organisation? *


    If other, please specify

    Which best describes your level of seniority? *

    If other, please specify

    Which areas are you responsible for or directly involved in? *

    If other, please specify

    What best describes your role in purchasing, investment, commissioning or adoption decisions? *

    Attendance Information

    Briefly, what is the number one thing you are hoping to get out of attending Life Sciences Week 2026? *

    Final Confirmation

    Is your role primarily focused on selling products or services, consultancy, account management or business development? *

    Please Confirm *

    I understand that VIP applications are subject to review and approval.
    I understand that the complimentary VIP Pass covers the Life Sciences Week Launch Day Conference only and does not include the Gala Dinner Awards or other separately ticketed events.
    The information supplied in this application is accurate.

    Shabna Raja

    Advisory Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

    She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
    initiatives across commercial, data and operating model domains within regulated environments.

    Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

    More recently, she has spent over three years working closely with Haleon through a strategic
    services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

    Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

    Amjad Khan

    Executive Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

    Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt and scale emerging  technologies to drive meaningful outcomes.

    Dr. Richard Fallon | Business Consultant | WM Life Sciences

    Dr. Richard Fallon

    Co Founder, Life Sciences Week 
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

    As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

    Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

    With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

    Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

    Amy Deakin | Chief of Staff | WM Life Sciences

    Amy Deakin

    Event Managing Director,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

    Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

    Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

    An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

      Award Category Voting

      Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

      Day you've not voted in, will be denoted with an ❌

      If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

      Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

      Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

      No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

      Awarding an individual or organisation for exceptional long-term impact on the industry.

      No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

      Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

      No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

      Your Details